{"data": [{"id": "1388981581142974464", "in_reply_to_user_id": "910581767966543872", "author_id": "3479642475", "text": "@Crypto_biscuit @AstraZeneca I\u2019m sure rollout will become stratified but the aim is to vaccinate as many as poss with avail supplies. Risk of long covid is reportedly higher so if it\u2019s Vaxzevria or nothing I\u2019d take my chances. Those I refer to are mainly in age groups where benefit/risk ratio is much higher!", "created_at": "2021-05-02T22:19:49.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "lang": "en"}, {"id": "1388792831989403652", "in_reply_to_user_id": "3479642475", "author_id": "910581767966543872", "text": "@mcal_87 @AstraZeneca EMA data shows for 40-49 age group (currently being vaccinated in UK) the clot risk is approx 1 in 50,000 or 0.02%. Not all will be fatal, but probable life-long consequences. UK should offer Pfizer to all under 50s IMO, esp when cases are low https://t.co/rrCOGfRwUr", "created_at": "2021-05-02T09:49:48.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 2, "quote_count": 0}, "lang": "en"}], "meta": {"newest_id": "1388981581142974464", "oldest_id": "1388792831989403652", "result_count": 2}}